
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on May 12, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,260 cr
Turnover Ratio
16.09%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 3.32%
- 1Y: 15.63%
- 3M: 3.03%
- 3Y: 23.73%
- 6M: -3.49%
- 5Y: 23.06%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
471.231 | 22.79% | 3,671 cr | 0.9% | - |
Other plans of Nippon India Pharma